Lilly To Provide Free Access to Drug Discovery Platform Under New Collaborative Initiative

Findings from the initiative "could ultimately form the basis for collaboration or licensing agreements between Lilly and external institutions," the company said.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.